These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11698073)
1. Regulation of immunoglobulin E-mediated secretion by protein phosphatases in human basophils and mast cells of skin and lung. Bastan R; Peirce MJ; Peachell PT Eur J Pharmacol; 2001 Oct; 430(1):135-41. PubMed ID: 11698073 [TBL] [Abstract][Full Text] [Related]
2. Characterization of protein serine/threonine phosphatase activities in human lung mast cells and basophils. Peirce MJ; Munday MR; Peachell PT Br J Pharmacol; 1998 Nov; 125(5):1095-101. PubMed ID: 9846650 [TBL] [Abstract][Full Text] [Related]
3. Preliminary characterization of the role of protein serine/threonine phosphatases in the regulation of human lung mast cell function. Peirce MJ; Cox SE; Munday MR; Peachell PT Br J Pharmacol; 1997 Jan; 120(2):239-46. PubMed ID: 9117116 [TBL] [Abstract][Full Text] [Related]
4. Regulation of human basophil function by phosphatase inhibitors. Peirce MJ; Warner JA; Munday MR; Peachell PT Br J Pharmacol; 1996 Sep; 119(2):446-53. PubMed ID: 8886433 [TBL] [Abstract][Full Text] [Related]
5. Regulation of human lung mast cell function by phosphatase inhibitors. Peachell PT; Munday MR J Immunol; 1993 Oct; 151(7):3808-16. PubMed ID: 7690815 [TBL] [Abstract][Full Text] [Related]
6. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. Favre B; Turowski P; Hemmings BA J Biol Chem; 1997 May; 272(21):13856-63. PubMed ID: 9153244 [TBL] [Abstract][Full Text] [Related]
7. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855 [TBL] [Abstract][Full Text] [Related]
8. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors. Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344 [TBL] [Abstract][Full Text] [Related]
9. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors. Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807 [TBL] [Abstract][Full Text] [Related]
10. Role of phosphoprotein phosphatases in the corpus luteum: I identification and characterisation of serine/threonine phosphoprotein phosphatases in isolated rat luteal cells. Ford SL; Abayasekara DR; Persaud SJ; Jones PM J Endocrinol; 1996 Aug; 150(2):205-11. PubMed ID: 8869587 [TBL] [Abstract][Full Text] [Related]
11. [Naturally occurring toxins with specific inhibitory activity against protein serine/threonine phosphatases 1 and 2A]. Takai A Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1091-101. PubMed ID: 9655967 [No Abstract] [Full Text] [Related]
12. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways. Chatfield K; Eastman A Biochem Biophys Res Commun; 2004 Oct; 323(4):1313-20. PubMed ID: 15451440 [TBL] [Abstract][Full Text] [Related]
13. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. Walsh AH; Cheng A; Honkanen RE FEBS Lett; 1997 Oct; 416(3):230-4. PubMed ID: 9373158 [TBL] [Abstract][Full Text] [Related]
14. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. McCluskey A; Sim AT; Sakoff JA J Med Chem; 2002 Mar; 45(6):1151-75. PubMed ID: 11881984 [No Abstract] [Full Text] [Related]
15. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2a regulates the activities of G(1) cyclin-dependent kinases. Yan Y; Mumby MC J Biol Chem; 1999 Nov; 274(45):31917-24. PubMed ID: 10542219 [TBL] [Abstract][Full Text] [Related]
16. Role of protein phosphatases in cyclic AMP-mediated stimulation of hepatic Na+/taurocholate cotransport. Mukhopadhyay S; Webster CR; Anwer MS J Biol Chem; 1998 Nov; 273(45):30039-45. PubMed ID: 9792726 [TBL] [Abstract][Full Text] [Related]
17. Effects of fostriecin on β2-adrenoceptor-driven responses in human mast cells. Bastan R; Eskandari N; J Ardakani H; T Peachell P J Immunotoxicol; 2017 Dec; 14(1):60-65. PubMed ID: 28090813 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors. Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665 [TBL] [Abstract][Full Text] [Related]
19. Effect of okadaic acid on immunologic and non-immunologic histamine release in rat mast cells. Estévez MD; Vieytes MR; Louzao MC; Botana LM Biochem Pharmacol; 1994 Feb; 47(3):591-3. PubMed ID: 8117330 [TBL] [Abstract][Full Text] [Related]
20. The effect of okadaic acid on histamine release, cell morphology and phosphorylation in rat basophilic leukemia (RBL-2H3) cells, human basophils and rat peritoneal mast cells. Kitani S; Teshima R; Nonomura Y; Morita Y; Ito K Int Arch Allergy Immunol; 1996 Aug; 110(4):339-47. PubMed ID: 8768801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]